Vestal Point Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.6M | Buy |
2,000,000
+700,000
| +54% | +$21.9M | 3.3% | 7 |
|
|
2025
Q1 | $43.6M | Buy |
1,300,000
+490,000
| +60% | +$16.4M | 3.11% | 9 |
|
|
2024
Q4 | $31.8M | Sell |
810,000
-15,000
| -2% | -$588K | 1.88% | 21 |
|
|
2024
Q3 | $32.5M | Buy |
825,000
+300,000
| +57% | +$11.8M | 2.46% | 16 |
|
|
2024
Q2 | $20.5M | Buy |
525,000
+125,000
| +31% | +$4.87M | 1.53% | 24 |
|
|
2024
Q1 | $17.2M | Buy |
400,000
+225,000
| +129% | +$9.69M | 1.42% | 17 |
|
|
2023
Q4 | $8.06M | Buy |
+175,000
| New | +$8.06M | 0.85% | 29 |
|